A downtrend has been apparent in Fresenius (FMS) lately. While the stock has lost 9.1% over the past four weeks, it could ...

On July 14, 2025 Fresenius filed two IPR petitions challenging Regeneron’s patents related to aflibercept. Regeneron has not asserted that ...

Fresenius Medical Care’s third-party CRO, Frenova announces strategic collaboration advancing genomics-driven, precision kidney disease care: Bad Homburg Saturday, August 2, 202 ...

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Fresenius Medical Care (FMS) is rated a buy, with shares up 32.95% YoY and strong Q1 2025 results, showing 60% (YoY) net ...

Fresenius Medical Care AG (NYSE:FMS) is one of the 13 Best German Stocks to Invest in Now. On July 3, the company announced it had partnered with Mexico’s Coordination of National Institutes of Health ...

Azenta, Inc. (Nasdaq: AZTA) today announced that it has entered a collaboration with Frenova, a division of Fresenius Medical Care, and Nephronomics, a Renal Precision Medicine company, to begin ...

Willmar has been home to a dialysis clinic since the 1960s when the city-owned Rice Memorial Hospital established a program. The clinic is now operated by Fresenius Kidney Care in a new location.

Fresenius’s medical care arm pointed to an “unprecedented” labor landscape in the U.S., as well, which led to “staff shortages, high turnover rates and meaningfully higher costs.” ...

Fresenius continues to hammer Akorn with allegations of fraud in its drug development and manufacturing as the German company battles to extract itself from its $4.3 billion buyout of the U.S.

Whistleblower Lawsuit Against Fresenius Alleges Unlawful Arrangements with Hospitals and Nephrologists Intended to Induce Dialysis Referrals Scott Downing, Jason Greis, Juan Morado Jr., Mark Silberman ...